JiangXi Tianxin Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

JiangXi Tianxin Pharmaceutical Co., Ltd.

Why is JiangXi Tianxin Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -4.10% and Operating profit at -8.53% over the last 5 years

With a fall in Net Sales of -8.67%, the company declared Very Negative results in Sep 25

INTEREST(HY) At CNY 5.47 MM has Grown at 165.22%
OPERATING CASH FLOW(Y) Lowest at CNY 550.35 MM
DEBT-EQUITY RATIO (HY) Highest at -24.1 %

Underperformed the market in the last 1 year

The stock has generated a return of 6.75% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is JiangXi Tianxin Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

JiangXi Tianxin Pharmaceutical Co., Ltd.

-17.03%

0.37

20.34%

China Shanghai Composite

19.22%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.34%

EBIT Growth (5y)

-9.83%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.29

Sales to Capital Employed (avg)

0.43

Tax Ratio

15.62%

Dividend Payout Ratio

40.46%

Pledged Shares

Institutional Holding

ROCE (avg)

28.29%

ROE (avg)

18.62%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.00

EV to EBIT

15.90

EV to EBITDA

12.60

EV to Capital Employed

2.30

EV to Sales

3.80

PEG Ratio

Dividend Yield

ROCE (Latest)

14.44%

ROE (Latest)

10.23%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-28What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 584.99 MM

ROCE(HY)

Lowest at 10.5%

DEBT-EQUITY RATIO (HY)

Highest at -22.69 %

INTEREST COVERAGE RATIO(Q)

Lowest at 1,752.76

RAW MATERIAL COST(Y)

Grown by 18.69% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.28 times

INTEREST(Q)

Highest at CNY 9.94 MM

PRE-TAX PROFIT(Q)

Fallen at -32.57%

NET PROFIT(Q)

Fallen at -33.31%

Here's what is not working for JiangXi Tianxin Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 584.99 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

At CNY 9.94 MM has Grown at 269.47%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 1,752.76

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at -22.69 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at CNY 9.94 MM

in the last five periods and Increased by 269.47% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Pre-Tax Profit

Fallen at -32.57%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Fallen at -33.31%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 2.28 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 18.69% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales